Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Mitessh Thakkar of mitesshthakkar.com suggests buying Reliance Industries.
Sharmila Joshi of sharmilajoshi.com is of the view that is of the view that one may prefer Glenmark Pharma, Sun Pharmaceutical and Lupin.
NTPC, Glenmark and GAIL, among others, are being tracked by investors on Monday.
Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma, Ajanta Pharma and Cipla.
The research house has increased its FY19/20 EPS estimates by 4/6 percent but cut FY18 EPS estimates by 5 percent.
HDFC, Somany and pharma, among others, are on the radar of investors on Tuesday.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Apollo Tyres, Dewan Housing Finance Corporation and Shree Cements and can sell Tata Motors and Glenmark Pharma.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bharat Financial, Ashok Leyland and Ambuja Cements and advises holding Vedanta.
Mitessh Thakkar of mitesshthakkar.com recommends selling Dish TV and Glenmark Pharma and advises buying HDFC Bank, Larsen and Toubro and PVR.
According to Ashwani Gujral of ashwanigujral.com, one may buy Larsen & Toubro and Indraprastha Gas.
Watch the interview of Andrew Holland CEO, Avendus Capital and Ashwani Gujral ashwanigujral.com with CNBC-TV18's Prashant Nair and Ekta Batra on CNBC-TV18, in which they shared their reading and outlook on markets and specific stocks.
Glenmark, L&T and HDFC Bank, among others, are on the radar of investors on Friday.
Ashwani Gujral of ashwanigujral.com advises buying Sobha and PC Jeweller and sell Glenmark Pharma.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Glenmark Pharma and Idea Cellular and buy Titan Company and prefers Maruti Suzuki over Amtek Auto.
Sudip Bandopadhyay, Market Expert recommends buuying Aurobindo Pharma, Natco Pharma and Glenmark Pharma and expects more than 20 percent upside in one year.
Sumeet Jain of Destimoney Securities is of the view that one may sell Multi Commodity Exchange of India (MCX) Future with a target of Rs 955.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Jubilant Foodworks, JSW Steel, BEML and Emami and sell Glenmark Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Tata Global Beverage and Hindustan Unilever and can sell Lupin, Sun Pharmaceutical Industries and Glenmark Pharma.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Vedanta and Apollo Tyres and sell Tata Communications, Glenmark Pharma and UPL.
Sudip Bandhopadhyay, Market Expert is of the view that one can buy Aurobindo Pharma and likes Glenmark Pharma as well as Natco Pharma..
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com in which he shared his readings and outlook on market and specific stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18's Surabhi Upadhyay and Prashant Nair, SP Tulsian of sptulsian shared his views and outlook on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18, Surajit Pal of Prabhudas Lilladher shared his views and readings on two stocks from pharma space - Glenmark Pharma and Biocon.